0BU14KZ
Supplement Trachea to No Qualifier with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | B Respiratory System |
| Operation | U Supplement |
| Body Part | 1 Trachea |
| Approach | 4 Percutaneous Endoscopic |
| Device | K Nonautologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
This family covers procedures that reinforce or add bulk to a weakened or structurally deficient part of the airway or its supporting structures, such as the trachea, bronchi, or diaphragm, using either the patient's own tissue, donor tissue, or a synthetic material like mesh or a patch. The goal is not to replace the body part but to shore it up so it can keep doing its normal job - for example, patching a floppy section of trachea that collapses with breathing, or reinforcing a diaphragm that has thinned or herniated. Surgeons turn to these procedures when a segment of the airway or diaphragm is intact but too weak or malformed to function reliably on its own.
Patients typically encounter this after a diagnosis of tracheomalacia, a diaphragmatic defect, or a previous repair that has stretched or failed over time. Because the underlying anatomy stays in place and is simply strengthened, recovery generally focuses on protecting the reinforced area from strain while it heals into the surrounding tissue.
Anatomy & Axis Detail
Trachea
The trachea is the cartilage-ringed airway connecting the larynx to the bronchial tree, and supplementing it involves reinforcing a weakened, stenotic, or previously repaired segment with autologous tissue or biological graft material rather than replacing the airway outright. This is typically performed for tracheomalacia, post-intubation stricture, or after prior tracheal surgery where the wall lacks adequate structural support, using material such as cartilage grafts or synthetic mesh sewn along the affected segment to restore rigidity and prevent airway collapse. Because the trachea sits centrally in the neck and upper mediastinum in close relation to the esophagus, recurrent laryngeal nerves, and great vessels, augmentation procedures demand precise placement to avoid compromising these adjacent structures while achieving a patent, stable airway.
Approach: Percutaneous Endoscopic
Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.
Device: Nonautologous Tissue Substitute
Nonautologous Tissue Substitute refers to biologic material sourced from a donor or another species, such as an allograft or xenograft, used to replace a body part. It differs from Autologous Tissue Substitute by tissue origin outside the patient's own body, and from Synthetic Substitute by being biologic rather than manufactured material.
Coding & Documentation
Coders assign Supplement here when the operative note describes material being laid onto or into an existing body part to add support or bulk, not to replace it outright - watch for phrasing like "reinforced with mesh," "patch graft applied," or "augmented." The documentation needs to identify the specific body part reinforced and the type of material used, since the device character value (autologous, synthetic, nonautologous) changes based on it.
The most common error is confusing Supplement with Replacement when a device fully substitutes for a body part rather than reinforcing it, or missing that a repair using only suture material (no separate device) should instead be coded as Repair.